Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

TSE:RX Stock Latest News

Company AnnouncementsBioSyent Targets Investor Visibility with Planet MicroCap Toronto Appearance1w ago

Company AnnouncementsBioSyent Earns Spot on Canada’s Top Growing Companies 2026 List1M ago
RatingsBioSyent: Buy Rating Reiterated as Revenue Nearly Doubles; $18 Price Target Maintained on Strong Growth Trajectory2M ago
Company AnnouncementsBioSyent Maintains Quarterly Dividend as Specialty Healthcare Growth Continues2M ago
Company AnnouncementsBioSyent’s New Oral Health Segment Powers Surging Q2 2026 Earnings2M ago

RatingsBioSyent Earns Buy Rating as Analyst Cites Thyconvi Launch, Competitive Moat and Lifts Price Target to $184M ago

RatingsDavid Martin Reiterates Buy on BioSyent, Keeps Price Target Unchanged at $16.50 After Strong Q1 and Oral Science Momentum5M ago

Company AnnouncementsBioSyent to Showcase Growth Strategy at 2026 Bloom Burton Healthcare Investor Conference6M ago

Company AnnouncementsBioSyent’s FeraMAX Tops Canadian Iron Supplement Rankings for 11th Straight Year7M ago
Company AnnouncementsBioSyent Grants Restricted Share Units to Key Personnel7M ago
RatingsBuy Rating on BioSyent: Solid Core Franchise and Timing-Related Weakness Create Attractive Risk‑Reward7M ago
Company AnnouncementsBioSyent Delivers Double-Digit 2025 Growth and Expands with Oral Health Acquisition7M ago

Company AnnouncementsBioSyent Closes $25.5 Million Acquisition of Dental Specialist Oral Science8M ago

Company AnnouncementsBioSyent to Buy Oral Science in $25.5 Million Deal to Expand Oral Health Portfolio8M ago

Company AnnouncementsBioSyent Hikes Quarterly Dividend 10% for First Quarter 20269M ago

Company AnnouncementsBioSyent Renews Share Repurchase Program to Enhance Shareholder Value10M ago
RatingsBioSyent’s Strong Q3 2025 Performance and Diversified Revenue Streams Justify Buy Rating11M ago
Company AnnouncementsBioSyent Reports Strong Financial Growth in Q3 and YTD 202511M ago
Company AnnouncementsBioSyent to Announce Q3 and YTD 2025 Financial Results on November 2011M ago

BioSyent Inc. Reports Strong Growth Amid Challenges

Company AnnouncementsBioSyent Inc. Reports Strong Growth Amid Challenges1y agoRX

RatingsBioSyent: Consistent Performance and Strategic Initiatives Drive Buy Rating1y ago

Company AnnouncementsBioSyent Inc. Reports Robust Growth in Q2 and H1 2025 Financial Results1y ago